Literature DB >> 30361904

Non-target Genes Regulate miRNAs-Mediated Migration Steering of Colorectal Carcinoma.

Sohair M Salem1, Ahmed R Hamed2,3, Alaaeldin G Fayez4, Ghada Nour Eldeen4,5.   

Abstract

MicroRNAs (miRNAs) trigger a two-layer regulatory network directly or through transcription factors and their co-regulators. Unlike miR-375, the role of miR-145 and miR-224 in inhibiting or driving cancer cell migration is controversial. This study is a step towards addressing the potential of miR-375, miR-145 and miR-224 expression modulation to inhibit colorectal carcinoma (CRC) cells migration in vitro through regulation of non-target genes VEGFA, TGFβ1, IGF1, CD105 and CD44. Transwell migration assay results revealed a significant subdue of migration ability of cells transfected with miR-375 and miR-145 mimics and miR-224 inhibitor. Real time PCR data showed that expression of VEGFA, TGFβ1, IGF1, CD105 and CD44 was downregulated as a consequence of exogenous re-expression of miR-375 and inhibition of miR-224. On the other hand, ectopic expression of miR-145 did not affect VEGFA, TGFβ1 and CD44 expression, while it elevated CD105 and suppressed IGF1 expression. MAP4K4, a predicted target of miR-145, was validated as a target that could play a role in miR-145-mediated regulation of migration. At mRNA level, no change was observed in expression of MAP4K4 in cells with restored expression of miR-145, while western blotting analysis revealed a 25% reduction of protein level. By applying luciferase reporter assay, a significant decrease in luciferase activity was observed, supporting that miR-145 directly target 3' UTR of MAP4K4. The study highlighted the involvement of non-target genes VEGFA, TGFβ1, IGF1, CD105 and CD44 in mediating anti- and pro-migratory effect of miR-375 and miR-224, respectively, and validated MAP4K4 as a direct target of anti-migratory miR-145.

Entities:  

Keywords:  MAP4K4; MiRNAs, colorectal carcinoma; Migration; Non-target genes

Mesh:

Substances:

Year:  2018        PMID: 30361904     DOI: 10.1007/s12253-018-0502-9

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  54 in total

1.  Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis.

Authors:  Q Yu; I Stamenkovic
Journal:  Genes Dev       Date:  2000-01-15       Impact factor: 11.361

2.  Identification and functional characterization of a novel human misshapen/Nck interacting kinase-related kinase, hMINK beta.

Authors:  Yuanming Hu; Cindy Leo; Simon Yu; Betty C B Huang; Hank Wang; Mary Shen; Ying Luo; Sarkiz Daniel-Issakani; Donald G Payan; Xiang Xu
Journal:  J Biol Chem       Date:  2004-10-06       Impact factor: 5.157

Review 3.  MicroRNA function: multiple mechanisms for a tiny RNA?

Authors:  Ramesh S Pillai
Journal:  RNA       Date:  2005-12       Impact factor: 4.942

4.  Expression analysis of VEGFA, FGF2, TGFbeta1, EGF and IGF1 in human nasal polyposis.

Authors:  Apostolos Zaravinos; Giannoula Soufla; John Bizakis; Demetrios A Spandidos
Journal:  Oncol Rep       Date:  2008-02       Impact factor: 3.906

5.  Expression of liver-specific markers in naïve adipose-derived mesenchymal stem cells.

Authors:  Romy Zemel; Larisa Bachmetov; Dean Ad-El; Amir Abraham; Ran Tur-Kaspa
Journal:  Liver Int       Date:  2009-06-05       Impact factor: 5.828

6.  A small interfering RNA screen for modulators of tumor cell motility identifies MAP4K4 as a promigratory kinase.

Authors:  Cynthia S Collins; Jiyong Hong; Lisa Sapinoso; Yingyao Zhou; Zheng Liu; Kenneth Micklash; Peter G Schultz; Garret M Hampton
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-28       Impact factor: 11.205

7.  Transforming growth factor-beta1 and CD105 promote the migration of hepatocellular carcinoma-derived endothelium.

Authors:  Anna Benetti; Angiola Berenzi; Marco Gambarotti; Emirena Garrafa; Maurizio Gelati; Enrico Dessy; Nazario Portolani; Tullio Piardi; Stefano Maria Giulini; Arnaldo Caruso; Gloria Invernici; Eugenio Agostino Parati; Roberto Nicosia; Giulio Alessandri
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

8.  Reduced accumulation of specific microRNAs in colorectal neoplasia.

Authors:  Michael Z Michael; Susan M O' Connor; Nicholas G van Holst Pellekaan; Graeme P Young; Robert J James
Journal:  Mol Cancer Res       Date:  2003-10       Impact factor: 5.852

9.  Endoglin promotes transforming growth factor beta-mediated Smad 1/5/8 signaling and inhibits endothelial cell migration through its association with GIPC.

Authors:  Nam Y Lee; Bridgette Ray; Tam How; Gerard C Blobe
Journal:  J Biol Chem       Date:  2008-09-05       Impact factor: 5.157

10.  Inhibiting colorectal carcinoma growth and metastasis by blocking the expression of VEGF using RNA interference.

Authors:  Shaochuang Wang; Hui Liu; Lifeng Ren; Yifeng Pan; Yangde Zhang
Journal:  Neoplasia       Date:  2008-04       Impact factor: 5.715

View more
  2 in total

1.  Development of MAP4 Kinase Inhibitors as Motor Neuron-Protecting Agents.

Authors:  Pieter H Bos; Emily R Lowry; Jonathon Costa; Sebastian Thams; Alejandro Garcia-Diaz; Arie Zask; Hynek Wichterle; Brent R Stockwell
Journal:  Cell Chem Biol       Date:  2019-10-31       Impact factor: 8.116

Review 2.  Function and mechanisms of microRNA-20a in colorectal cancer.

Authors:  Zheng Xiao; Shi Chen; Shujun Feng; Yukun Li; Juan Zou; Hui Ling; Ying Zeng; Xi Zeng
Journal:  Exp Ther Med       Date:  2020-01-08       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.